OrthoPediatrics Corp (KIDS)
25.93
+0.29
(+1.13%)
USD |
NASDAQ |
Oct 04, 16:00
25.91
-0.02
(-0.08%)
Pre-Market: 20:00
OrthoPediatrics Research and Development Expense (TTM): 10.68M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.68M |
| March 31, 2024 | 11.10M |
| December 31, 2023 | 10.55M |
| September 30, 2023 | 9.833M |
| June 30, 2023 | 9.652M |
| March 31, 2023 | 8.433M |
| December 31, 2022 | 8.014M |
| September 30, 2022 | 7.588M |
| June 30, 2022 | 6.684M |
| March 31, 2022 | 6.262M |
| December 31, 2021 | 5.543M |
| September 30, 2021 | 5.985M |
| June 30, 2021 | 5.76M |
| March 31, 2021 | 5.316M |
| December 31, 2020 | 5.273M |
| September 30, 2020 | 5.128M |
| Date | Value |
|---|---|
| June 30, 2020 | 5.447M |
| March 31, 2020 | 5.80M |
| December 31, 2019 | 5.748M |
| September 30, 2019 | 5.12M |
| June 30, 2019 | 4.846M |
| March 31, 2019 | 4.727M |
| December 31, 2018 | 4.732M |
| September 30, 2018 | 4.396M |
| June 30, 2018 | 4.401M |
| March 31, 2018 | 3.954M |
| December 31, 2017 | 3.423M |
| September 30, 2017 | 3.106M |
| June 30, 2017 | 2.48M |
| March 31, 2017 | 2.401M |
| December 31, 2016 | 2.221M |
| September 30, 2016 | 2.076M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.128M
Minimum
Sep 2020
11.10M
Maximum
Mar 2024
7.304M
Average
6.262M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| The Cooper Companies Inc | 154.10M |
| Staar Surgical Co | 49.77M |
| NexGel Inc | 0.097M |
| Innovative Eyewear Inc | 0.7866M |
| Perspective Therapeutics Inc | 28.53M |